Windlas Biotech Ltd

BSE: 543329

total announcements

543329.BO · 15 min delayed

BSEAGM/EGMResults24 Jul 2026

Windlas Biotech Ltd

Submission of Combined Voting Results and Scrutinizer's Report under Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') ....

Windlas Biotech Ltd has submitted the combined voting results and scrutinizer's report for its 25th Annual General Meeting held on July 23, 2026. The report reveals that all resolutions were passed with the requisite majority. The company's financial statements for the financial year ended March 31, 2026, were approved, and a final dividend of Rs. 6.30 per equity share for the financial year 2025-26 was declared. The appointment of a director in place of Mr. Hitesh Windlass, Managing Director, was also approved.

Proceedings of 25th Annual General Meeting of the Company held on July 23, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Windlas Biotech Ltd held its 25th Annual General Meeting on July 23, 2026, through video conferencing. The meeting was attended by 63 members, and the resolutions related to the adoption of audited financial statements, declaration of final dividend, appointment of directors, ratification of cost auditor remuneration, and appointment of an independent director were passed. The voting results will be placed on the company's website and stock exchange websites.